ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,483Medicare Part D Prescriptions Filled, Including Refills

Rank: 354 out of 972

$504K Total Retail Price of All Prescriptions

Rank: 311 out of 972

153 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 153 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 153 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,483 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

55 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
FUROSEMIDE 355 317 1 7
WARFARIN SODIUM 316 237 2 12
HYDROCODONE-ACETAMINOPHEN 241 188 S3 3 6
LISINOPRIL 232 188 4 1
LEVOTHYROXINE SODIUM 226 191 5 3
OMEPRAZOLE 223 196 6 5
NAMENDA 216 204 7 38
POTASSIUM CHLORIDE 202 171 8 13
METOPROLOL TARTRATE 198 159 9 9
IPRATROPIUM-ALBUTEROL 196 151 10 132
AMLODIPINE BESYLATE 184 158 11 4
DONEPEZIL HCL 178 154 12 26
MIRTAZAPINE 143 118 13 46
GABAPENTIN 138 84 14 14
SERTRALINE HCL 137 86 15 25
CITALOPRAM HBR 116 99 16 19
BACLOFEN 115 51 17 123
SIMVASTATIN 112 107 18 2
OXYCODONE-ACETAMINOPHEN 107 47 S2 19 80
QUETIAPINE FUMARATE 106 102 20 83
LANTUS 99 74 21 44
DIGOXIN 91 91 22 52
CYMBALTA 91 63 22 49
TRAZODONE HCL 86 58 24 35
PREDNISONE 79 74 25 40
CARBIDOPA-LEVODOPA 77 50 26 87
KLOR-CON M20 77 72 26 78
NOVOLOG 74 50 28 100
METFORMIN HCL 73 61 29 8
ISOSORBIDE MONONITRATE ER 70 70 30 43
POLYETHYLENE GLYCOL 3350 68 56 31 67
HYDROCHLOROTHIAZIDE 68 43 31 10
RISPERIDONE 68 58 31 76
LEVETIRACETAM 67 35 34 111
TAMSULOSIN HCL 67 50 34 29
ESCITALOPRAM OXALATE 66 66 36 65
METOPROLOL SUCCINATE 62 51 37 16
DIVALPROEX SODIUM 62 62 37 96
FAMOTIDINE 60 31 39 73
PAROXETINE HCL 58 29 40 64
SANTYL 53 37 41 189
SPIRONOLACTONE 52 33 42 54
EXELON 51 51 43 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.